key: cord-0769533-587wmhfi
authors: Madrazo González, Zoilo; Osorio Aguilar, Javier; Videla Cés, Sebastián; Sainz Villacampa, Beatriz; Rodríguez-González, Araceli; Campos Serra, Andrea; Santamaría Gómez, Maite; Pelegrina Manzano, Amalia; González-Serrano, Carmen; Aldeano Martín, Aurora; Sarriugarte Lasarte, Aingeru; Gómez-Díaz, Carlos Javier; Ruiz-Luna, David; García-Ruiz-de-Gordejuela, Amador; Gómez-Gavara, Concepción; Gil-Barrionuevo, Marta; Vila Tura, Marina; Clavell Font, Arantxa; Campillo Alonso, Beatriz; Millán Paredes, Laura; Olona Casas, Carles; Sánchez-Cordero, Sergi; Medrano Caviedes, Rodrigo; López-Arévalo, Camilo Andrés; Pérez-Romero, Noelia; Artigau Nieto, Eva; Calle Baraja, Miguel; Echenagusia Serrats, Víctor; Otero González, Aurema; Tebé Cordomí, Cristian; Pallarès Fontanet, Natàlia; Biondo, Sebastiano
title: P-POSSUM as mortality predictor in COVID-19-infected patients submitted to emergency digestive surgery. A retrospective cohort study
date: 2021-11-11
journal: Int J Surg
DOI: 10.1016/j.ijsu.2021.106171
sha: b0d82a396709bd521230ea75bc7a7e00abf11428
doc_id: 769533
cord_uid: 587wmhfi

BACKGROUND: COVID-19 infection is associated with a higher mortality rate in surgical patients, but surgical risk scores have not been validated in the emergency setting. [Reviewer #1, Comment #2] [Reviewer #2, Comment #1] We aimed to study the capacity for postoperative mortality prediction of the P-POSSUM score in COVID-19-positive patients submitted to emergency general and digestive surgery. MATERIAL AND METHODS: Consecutive patients undergoing emergency general and digestive surgery from March to June 2020, and from March to June 2019 in 25 Spanish hospitals were included in a retrospective cohort study. Main outcome: 30-day mortality. P-POSSUM discrimination was quantified by the area under the curve (AUC) of ROC curves; calibration was assessed by linear regression slope (β estimator); and sensitivity and specificity were expressed as percentage and 95% confidence interval (CI). RESULTS: 4988 patients were included: 177 COVID-19-positive; 2011 intra-pandemic COVID-19-negative; and 2800 pre-pandemic. COVID-19-positive patients were older, with higher surgical risk, more advanced pathologies, and higher P-POSSUM values (1.79% vs. 1.09%, p < 0.001, [Reviewer #2, Comment #6] in both the COVID-19-negative and control cohort). 30-day mortality in the COVID-19-positive, intra-pandemic COVID-19-negative and pre-pandemic cohorts were: 12.9%, 4.6%, and 3.2%. The P-POSSUM predictive values in the three cohorts were, respectively: AUC 0.88 (95% CI 0.81–0.95), 0.89 (95% CI 0.87–0.92), and 0.91 (95% CI 0.88–0.93); β value 0.97 (95% CI 0.74–1.2), 0.99 (95% CI 0.82–1.16), and 0.78 (95% CI 0.74–0.82); sensitivity 83% (95% CI 61–95), 91% (95% CI 84–96), and 89% (95% CI 80–94); and specificity 81% (95% CI 74–87), 76% (95% CI 74–78), and 80% (95% CI 79–82). CONCLUSION: The P-POSSUM score showed a good [Reviewer #2, Comment #9] predictive capacity for postoperative mortality in COVID-19-positive patients submitted to emergency general and digestive surgery. [Reviewer #1, Comment #2] [Reviewer #2, Comment #2]

to the different context in which clinical care was provided [19] . [Reviewer #2, 1 Comment #3] [Reviewer #2, Comment #5] 2 COVID-19 infection was assessed by reverse-transcriptase-polymerase-chain-reaction 3 test (RT-PCR) on nasopharyngeal swab. 4

The study protocol was approved by the Clinical Research Ethics Committee of the 5 leading and collaborating centers, and it has been previously published [1920] . Patients' 6 informed consent was waived given the retrospective nature of the study. The study was 7 designed in compliance with the principles of the Declaration of Helsinki and reported 8 following the recommendations of the STROCSS 2019 guideline [2021] . 9

Confidentiality was guaranteed in accordance with current Spanish legislation (LOPD 10 3/2018). Official study registry: ClinicalTrials.gov XXX, July 21 st , 2020. The COVID-11 CIR project has been awarded a research grant from the Catalan Society of Surgery 12 (Spain), intended entirely for electronic Case Report Form design and statistical 13 analysis. 14 15

This study was based in the multicenter COVID-CIR registry, including data from 17 electronic medical records by the participating hospitals (COVID-CIR Collaborative 18

Group, fully detailed in Supplemental file) [1920] . Anonymized data were entered into 19 an electronic Case Report Form (eCRF), based on the REDCap  platform (Research 20 Electronic Data Capture) [2122] . Before analysis, the principal investigators (JO, ZM 21 and SV) confirmed completeness and accuracy of data with senior surgeons from each 22 center. Demographic data included: age, sex, body mass index, ASA (American Society 23 of Anesthesiologists) score [2223] , functional status [2324] , arterial hypertension, 24 diabetes, smoking, chronic obstructive pulmonary disease (COPD) and cardiovascular 1 disease. 2

The P-POSSUM risk scoring system is based on 12 preoperative parameters [6-8]: age, 3 cardiac system, respiratory system, systolic blood pressure, heart rate, Glasgow coma 4 score, electrocardiographic findings, and urea, sodium, potassium, hemoglobin and 5 leukocyte values; and on 6 intraoperative variables [6] [7] [8] : surgical complexity, number 6 of surgical procedures, blood loss, peritoneal fluid appearance, neoplasm and surgical 7 priority. Complexity of procedures was categorized as "minor, moderate, major or 8 major-plus", according to the original definitions of the POSSUM score [6] . Surgical 9 priority was classified as "emergency", if surgery was required within two hours from 10 arrival at the emergency department, or "urgency", if surgical intervention was required 11 during the first 24 hours [6] . Each variable was weighted according to an exponential 12 scoring system and the P-POSSUM score was calculated in each cohort according to the 13 Due to the descriptive design of the study, calculation of the sample size was not 5 performed, being defined by the number of patients fulfilling inclusion criteria and 6 complete data operated on during the study periods. 7

Quantitative variables were described by means and standard deviation or median and 8 interquartile range, and qualitative variables by absolute number and percentage. 9

Incidences of complications, pulmonary complications [Reviewer #2, Comment #7], 10 severe complications and mortality were expressed by percentage and 95% confidence 11 interval (95% CI). 12

Discrimination is defined as the ability of the score to assign a higher risk of mortality 13 to patients who eventually die and a lower risk to those who survive, and was quantified 14 using the value of the area under the curve (AUC, including its 95% CI) of the Receiver 15

Operating Characteristic graphs (ROC curves) in each cohort [2627] . Figures from AUC 16 0.7-0.8 give a score an acceptable value; AUC 0.8-0.9 values qualify it as excellent; 17 AUC figures >0.9 allow us to consider a score as outstanding [2728] . 18

Calibration refers to the ability of a model to predict the response variable. To assess 19 calibration, the expected and observed incidence of each event in deciles of predicted 20 risk was compared graphically. The estimator of the linear regression slope ( value) 21 between the observed and expected incidents in each decile was reported. A slope close 22 to 1 suggests that there are no differences between the observed incidence and that 23 expected by the model; a slope <1 suggests an underestimation of risk by the model; 24 and a slope >1, an overestimation of risk. The slope estimator is accompanied by a 95% 1 CI to facilitate its interpretation. 2

In order to estimate an optimal cut-off for P-POSSUM score that best discriminates 3 between patients alive and those who died, we used the Youden index maximization 4 method [2829] . Bootstrap method was used to determine the 95% CI. With the cut-off 5 in each cohort, sensitivity, specificity, positive and negative predictive values, and 6 positive and negative likelihood ratios were calculated in each cohort and expressed as a 7 value or percentage and 95% CI [2829] . 8 Statistical analysis and graphic representations were developed using R version 3.6.3 9 computer software (R Core Team [2020] 

The COVID-CIR registry originally included 5,307 patients who underwent urgent 19 digestive or general surgery during the study periods. The population of this study is 20 made up of 4,988 patients who presented all variables needed to calculate the P-21 POSSUM score and complete 30 days follow-up. Of these operated patients, during 22 the pandemic period 177 tested positive for COVID-19, 2,011 tested negative for 23 COVID-19; and 2,800 patients correspond to the pre-pandemic period (Fig. 1) . 24

Demographic characteristics, risk factors, comorbidities, functional status, inflammatory 1 parameters, and P-POSSUM score variables of the three cohorts are detailed in Table 1 . 2 COVID-19-positive patients, compared to COVID-19-negative ones, were older, with 3 higher ASA scores, more functionally dependent, with more comorbidities, higher 4 inflammatory markers and indexes, higher lymphopenia rate, greater incidence of 5 peritonitis and malignancy, and more often submitted to emergent procedures and 6 "major" or "major-plus" complexity procedures. P-POSSUM value was higher in 7 COVID-19-positive patients (9%  19 vs. 4%  10 in both the COVID-19-negative and 8 control cohort). P-POSSUM value was higher in COVID-19-positive patients than in 9 the intra-pandemic COVID-19-negative and the pre-pandemic cohorts [median (IQR)]: 10 1.79% (0.78-5.55) vs. 1.09% (0.59-3.02) and 1.09% (0.58-2.94), p < 0.001. [Reviewer 11 #2, comment #6] 12 A total of 5,318 surgical procedures were performed in the three cohorts, detailed in 13 

Main outcomes of the study population are shown in Table 3 for procedures considered as "minor", "moderate", and "major"; regarding "major-plus" 2 procedures, postoperative mortality was similar between intra-pandemic COVID-19-3 positive and COVID-19-negative patients, but higher than pre-pandemic ones. 4

Procedures considered as emergent were associated with higher mortality than urgent 5 ones in each of the three cohorts. 6 7 3.3 P-POSSUM mortality prediction 8 P-POSSUM score values were higher in the patients who died, compared to the 9 survivors: 36% vs. 5% in the COVID-19-positive cohort; 23% vs. 3% in the pandemic 10 COVID-19-negative cohort; and 26% vs. 4% in the 2019 cohort. 11

The discriminative capacity of the P-POSSUM score, defined by the AUC value of the 12 ROC curve, is shown in Fig. 2 . 13

The calibration analysis did not show significant differences between the observed and 14 estimated mortality rates in the COVID-19-positive cohort nor in the COVID-19-15 negative cohort, reflecting an adequate calibration (Fig. 3) . The calibration of the P-16 POSSUM score in the 2019 cohort showed differences in the deciles with the highest 17 predicted risk. According to the optimal cut-off point, the detailed predictive 18 characteristics of the P-POSSUM score in each cohort (sensitivity, specificity, positive 19 and negative predictive values, positive and negative likelihood ratios) are reflected in 20 The results of this cohorts' study support the use of P-POSSUM prognostic scoring 24 system as a tool for estimating postoperative mortality in patients infected by SARS-25

CoV-2 submitted to emergency general and digestive surgery. It also proved its 1 predictive value for COVID-19-negative patients in the stressful context of COVID-19 2 pandemic. [Reviewer #2, Comments #3] [Reviewer #2, Comments #5] The study is 3 based on one of the most extensive series of consecutive patients operated on for 4 emergency surgery during the COVID-19 pandemic period published to date and, to our 5 knowledge, the first one analyzing the predictive capacity of the P-POSSUM score in 6 this particular epidemiological context. 7

Emergency surgery is at higher risk of postoperative complications and mortality than 8 elective procedures, due to the clinical deterioration secondary to the acute disease and 9 the lack of a preoperative period to optimize comorbidities and correct organ 10 dysfunction [3, 2930] . Postoperative mortality is the most significant prognostic measure 11 in the field of surgical care. However, raw mortality rate is difficult to evaluate without 12 adequate risk stratification. Different predictive scores for surgical risk have been 13 patients, as shown in a recent meta-analysis reporting a 24-28% mortality rate (odds 25 ratio 7.9) [15] . In the present study, 30-day mortality of COVID-19-infected patients 1 was 12.9%, greater than the 4.6% of contemporary COVID-19-negative ones. Based on 2 these similar findings, many authors and guidelines recommend delaying or avoiding 3 surgery whenever possible in case of 16] . However, raw 4 postoperative outcomes should be evaluated with caution, as COVID-19-positive 5 patients in the present and previous studies were older, with more comorbidities, and 6 higher anesthetic risk. It is unclear if increased postoperative mortality risk of COVID-7

19-infected patients is more in relation to their basal comorbidities and the severity of 8 disease at presentation or to a specific effect of COVID-19 infection. Therefore, a 9 general therapeutical recommendation is not acceptable for all potentially surgical 10 COVID-19-positive cases; it is of paramount importance to weigh the risk of 11 performing surgery against the risk of avoiding or delaying it in each individual case. 12

To our knowledge, only one surgical prognostic score has been tested in COVID-19- This study has some limitations. It only involves one country, a fact that could limit 14 generalizability of the results. However, it represents a largely homogeneous population 15 base and it could minimize selection bias. Its retrospective design is a further limitation, 16 which was intended to be minimized by the thorough data quality control and the 17 exclusion of patients with relevant missing variables. Besides, it must be noted that 18 some relevant prognostic parameters not included in the P-POSSUM score were not 19 recorded in the COVID-CIR register, such as nutritional state or clinical frailty. The 20 applicability of the findings may be limited in the current context due to generalization 21 of the COVID-19 vaccination and the natural immunity conferred by previous COVID-22

19 infection. However, as we found P-POSSUM score is a useful mortality predictor 23 both in COVID-19-positive and -negative patients, it is presumable that it will also 24 work for patients that suffered from COVID-19 in the past. [Reviewer #3, Comment #1] 25 Finally, the study did not provide a comparative cohort of potentially surgical patients 1 submitted to conservative treatment. 2 3

The findings of the present cohort study suggest that the P-POSSUM score, a well-5 known and easily applicable risk-prediction tool, has an excellent good [Reviewer #2, 6

Comment #9] capacity in estimating postoperative mortality in COVID-19-infected 7 patients submitted to emergency general and digestive surgery. COVID-19-positive 8 surgical patients with a high P-POSSUM score should be considered as high-risk 9 patients and require closer postoperative monitoring for early detection of complications 10 to reduce postoperative mortality. 11

Funding: The COVID-CIR project has been awarded a research grant from XXX, 3 intended entirely for electronic Case Report Form design and statistical analysis. 4

Ethical approval: 5

The study protocol was approved by the Clinical Research Ethics Committee of the 6 leading and collaborating centers (Ethics and Clinical Investigation Committee of the 7 Hospital XXX, code PR169/20, date approval 05/05/20). 8

We thank all the professionals who have participated in the 9 registration and analysis of the data necessary to carry out this study. We express our 10 special thanks to the Biostatistics Unit of the XXX for institutional support. 11 12 Provenance and peer review not commissioned, externally peer-reviewed. 13 COVID-19-negative n = 2,011 c The "exploratory laparotomy" category includes: suspected intestinal perforation, 1 anastomotic dehiscence or peritonitis (22 cases); peritoneal carcinomatosis (14 cases); 2 massive intestinal ischemia (12 cases); suspected intestinal obstruction (9 cases); 3 suspected intestinal ischemia (6 cases); other surgical procedures (2 cases). 4 

International guidelines and 4 recommendations for surgery during Covid-19 pandemic: A Systematic Review

Prediction models for diagnosis 7 and prognosis of covid-19: systematic review and critical appraisal

Keys to interpreting predictive models for the patient with 10 COVID-19

Analysis of outcomes of emergency general 12 and gastrointestinal surgery during the COVID-19 pandemic

Guideline: Strengthening the reporting of cohort studies in 21 surgery

The REDCap consortium: Building an 23 international community of software platform partners

AUC: area under ROC curve; 95% CI: confidence interval of 95%

a Cut-off point of P-POSSUM score calculated by maximizing the Youden index 7 1. Name of the registry

Protocol Registration and Results System 2. Unique Identifying number or registration ID: NCT04479150 3. Hyperlink to your specific registration

Author contribution Please specify the contribution of each author to the paper, e.g. study design, data collections

Javier Osorio Aguilar: Conceptualization, Data curation, Funding acquisition, Investigation, Methodology, Validation, Writingoriginal draft preparation, Writing-review & editing

Gordejuela: Investigation. Concepción Gómez-Gavara: Investigation. Marta Gil-Barrionuevo: Investigation. Marina Vila Tura: Investigation. Arantxa Clavell Font: Investigation. Beatriz Campillo Alonso: Investigation. Laura Millán Paredes: Investigation. Carles Olona Casas: Investigation. Sergi Sánchez-Cordero: Investigation. Rodrigo Medrano Caviedes: Investigation. Camilo Andrés López-Arévalo: Investigation. Noelia Pérez-Romero: Investigation. Eva Artigau Nieto: Investigation. Miguel Calle Baraja: Investigation. Víctor Echenagusia Serrats: Investigation. Aurema Otero González: Investigation. Cristian Tebé Cordomí: Data curation, Formal analysis, Methodology, Software, Writing-original draft preparation. Natàlia Pallarès Fontanet: Data curation, Formal analysis, Methodology, Software, Writingoriginal draft preparation. Sebastiano Biondo: Conceptualization, Supervision. The COVID-CIR Collaborative group: Investigation

e Antecedent of ischemic heart disease, cerebrovascular accident (transient ischemic 6 attack, stroke) or peripheral artery disease. 7 f Respiratory system: normal, no dyspnea and chest X-ray with no signs of COPD; 8 dyspnea with exercise, dyspnea with exercise and/or chest X-ray with minimal signs of 9 COPD; limiting dyspnea, limiting dyspnea (1 landing) and/or chest X-ray with 10 moderate signs of COPD; dyspnea at rest, dyspnea at rest (>30 breaths/minute) and/or 11 chest X-ray with fibrosis or consolidation. 12 g Complexity of surgical procedures was considered as minor, moderate, major or 13 major-plus as defined originally in the POSSUM score 

The following additional information is required for submission. Please note that failure to respond to these questions/statements will mean your submission will be returned. If you have nothing to declare in any of these categories, then this should be stated.

The authors have no competing interests to declare.

The COVID-CIR project has been awarded a research grant from the Catalan Society of Surgery (Spain), intended entirely for electronic Case Report Form design and statistical analysis.

The study protocol was approved by the Clinical Research Ethics Committee of the leading and collaborating centers (Ethics and Clinical Investigation Committee of the Hospital Universitari de Bellvitge, code PR169/20, date approval 05/05/20).

The World Medical Association's Declaration of Helsinki 2013 states in article 35: 'Every research study involving human subjects must be registered in a publicly accessible database before recruitment of the first subject'. Editors of IJS require that all types of research studies involving human participants should be registered prospectively and failing that retrospectively. There are many places to register your research, and you can choose which is the most suitable for your needs:•https://www.clinicaltrials.gov/ -for all human studies -free •http://www.chictr.org.cn/index.aspx -for all human studies -free •https://www.researchregistry.com/ -for all human studies -charge •https://www.isrctn.com/ -for all human studies -charge •Prospero -for systematic reviews -free •There are many national registries approved by the UN that can be found here Elsevier does not support or endorse any registry.

The Guarantor is the one or more people who accept full responsibility for the work and/or the conduct of the study, had access to the data, and controlled the decision to publish. Please note that providing a guarantor is compulsory.

J o u r n a l P r e -p r o o fThe datasets generated and analysed during the current study are not publicly available but are available from the corresponding author on reasonable request.